RT Journal Article
SR Electronic
T1 Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes
JF Evidence Based Medicine
JO Evid Based Med
FD BMJ Publishing Group Ltd
SP 224
OP 224
DO 10.1136/ebmed-2016-110562
VO 21
IS 6
A1 Rene Rodriguez-Gutierrez
A1 Victor M Montori
YR 2016
UL http://ebm.bmj.com/content/21/6/224.abstract
AB